| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/15/1998 | US5807885 Amidine derivatives with nitric oxide synthetase activities |
| 09/15/1998 | US5807878 Tetrasubstituted imidazoles |
| 09/15/1998 | US5807844 Therapy for septic shock, infections, toxicity |
| 09/15/1998 | US5807823 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
| 09/15/1998 | US5807819 Using an oligopeptide |
| 09/15/1998 | US5807726 Nucleic acids encoding dog gastric lipase and their use for the production of polypeptides |
| 09/15/1998 | US5807721 Compound FO-1289, process of production with aspergillus and strain |
| 09/15/1998 | CA2036962C Process for the desilylation of a 4-silyloxy-tetrahydro-pyran-2-one |
| 09/15/1998 | CA1340047C 7-substituted derivatives of 3,5-dihydroxyhept-6-ynoic acid, a process for the preparation thereof, the use thereof as pharmaceuticals, and intermediates |
| 09/13/1998 | CA2231765A1 Use of pyrimidine derivatives for the prevention of cancer, on their own or in combination with other therapeutic measures |
| 09/11/1998 | WO1998039444A1 Protein kinase c inhibitor-like protein (ipkc-2) |
| 09/11/1998 | WO1998039432A1 Polynucleotides and polypeptides belonging to the uncoupling proteins family |
| 09/11/1998 | WO1998039344A1 Novel purine inhibitors of fructose-1,6-bisphosphatase |
| 09/11/1998 | WO1998039343A1 Novel benzimidazole inhibitors of fructose-1,6-bisphosphatase |
| 09/11/1998 | WO1998039303A1 Small molecules useful in the treatment of inflammatory disease |
| 09/11/1998 | WO1998039299A1 5-oxysubstituted chinolines and their use as cholesterol ester transfer proteins inhibitors |
| 09/11/1998 | WO1998039292A1 20-epi-22(r)-lower alkyl-substituted vitamin d derivatives and calcium metabolism improving agents containing the same as the active ingredient |
| 09/11/1998 | WO1998039284A1 Aryl- and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity |
| 09/11/1998 | WO1998039280A1 Phenylpropenone compounds and medicines containing the same |
| 09/11/1998 | WO1998039023A1 Treatment of cardiomyopathy |
| 09/11/1998 | WO1998030692A3 Human endosulfine gene |
| 09/11/1998 | CA2591710A1 Starter kit containing nicotinic acid compositions |
| 09/11/1998 | CA2574987A1 Nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
| 09/11/1998 | CA2283415A1 Aryl- and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity |
| 09/11/1998 | CA2283257A1 Phenylpropenone compounds and medicines containing the same |
| 09/11/1998 | CA2282709A1 Protein kinase c inhibitor-like protein (ipkc-2) |
| 09/11/1998 | CA2278547A1 Small molecules useful in the treatment of inflammatory disease |
| 09/11/1998 | CA2247799A1 Polynucleotides and polypeptides belonging to the uncoupling proteins family |
| 09/10/1998 | DE19709125A1 Substituierte Chinoline Substituted quinolines |
| 09/09/1998 | EP0863139A1 Benzoxazindione derivatives, process for their preparation and their use |
| 09/09/1998 | EP0862631A1 Luminal cholecystokinin-releasing factor |
| 09/09/1998 | EP0862630A2 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 09/09/1998 | EP0862625A1 Methods for modulation of cholesterol transport |
| 09/09/1998 | EP0862622A1 Rac-proteine kinase as therapeutic agent or in diagnostics |
| 09/09/1998 | EP0716649B1 5-arylindole derivatives |
| 09/09/1998 | CN1192751A Monocype chemotactic protein-4 |
| 09/09/1998 | CN1192739A N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists |
| 09/09/1998 | CN1192729A Benzamide derivatives and their use as vasopressin antagonists |
| 09/09/1998 | CN1192689A Appetite regulating compositions |
| 09/09/1998 | CN1192685A Use of alendronate for preventing osteoporosis |
| 09/08/1998 | US5804596 Administration; preferential incorporation of nutrients to lean body mass, not adipose tissue |
| 09/08/1998 | US5804573 With additive antioxidant, polyoxyalkyl stabilizer, carrier |
| 09/08/1998 | US5804570 Administering 4-amino-1-hydroxy-butylidene-1,1-bisphosphonate (alendronate) or salt to osteoporotic female |
| 09/08/1998 | US5804204 Potassium salts for treatment of hypertension |
| 09/08/1998 | CA2083475C Derivatives of ethanolamine, their preparation, and the pharmaceutical compositions containing them |
| 09/06/1998 | CA2199325A1 Cyclic analogs of pth and pthrp |
| 09/05/1998 | CA2230965A1 New benzoxazinedione derivatives, a method of producing them and the use thereof |
| 09/03/1998 | WO1998038320A1 Component of bromelain |
| 09/03/1998 | WO1998038179A1 Reverse hydroxamate derivatives as metalloprotease inhibitors |
| 09/03/1998 | WO1998038167A1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor |
| 09/03/1998 | WO1998038163A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | WO1998037901A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/03/1998 | WO1998037883A1 Forskohlin for promoting lean body mass |
| 09/03/1998 | WO1998037880A1 Inhibitors of leaderless protein export |
| 09/03/1998 | WO1998037877A1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | WO1998037874A1 Oral preparation for the prophylactic and therapeutic treatment of helicobacter sp. infection |
| 09/03/1998 | WO1998037873A2 Method for reducing secretion of apolipoprotein b in animals by administering conjugated linoleic acid |
| 09/03/1998 | WO1998037773A1 Process for preparing a nutritional supplement |
| 09/03/1998 | WO1998029566A3 Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 09/03/1998 | CA2282656A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | CA2282655A1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | CA2281925A1 Inhibitors of leaderless protein export |
| 09/03/1998 | CA2281664A1 Reverse hydroxamate derivatives as metalloprotease inhibitors |
| 09/03/1998 | CA2281567A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/03/1998 | CA2279887A1 Method for reducing secretion of apolipoprotein b in animals by administering conjugated linoleic acid |
| 09/02/1998 | EP0861898A1 Rat Cathepsin K polynucleotide & polypeptide sequence |
| 09/02/1998 | EP0861851A1 Lys (B28) insulins. Human insulin analogues |
| 09/02/1998 | EP0861837A1 2-Aminoindane derivatives, process for their preparation and pharmaceutical compositions containing them |
| 09/02/1998 | EP0861666A2 Pharmaceutical composition for use in treatment of diabetes |
| 09/02/1998 | EP0861595A1 Gymnema inodorum roasted tea and method for preparing the same |
| 09/02/1998 | EP0861260A1 Improved method and agents for inhibiting protein aging |
| 09/02/1998 | EP0861240A1 Processes and intermediates for preparing 1-(2- 2-isoxazol-3-ylbenzofuran-5-yloxy]ethylamino)-3-phenoxy-2(s)-ol |
| 09/02/1998 | EP0861238A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| 09/02/1998 | EP0861074A1 Non-ionic surfactant vesicles as therapeutic agent |
| 09/02/1998 | EP0766696B1 Thiazolidine derivatives, their preparation and drugs containing same |
| 09/02/1998 | EP0533898B1 Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions |
| 09/02/1998 | CN1192156A Treatment of T cell mediated autoimmune disorders |
| 09/02/1998 | CN1192145A Methods for minimizing bone loss |
| 09/02/1998 | CN1191898A Self-enhancing, pharmacologically controllable expression systems |
| 09/02/1998 | CN1191862A 8-substituted-1,3,8-triaza-spiro £4,5| decan-4-on derivatives |
| 09/02/1998 | CN1039642C Derivative of hexahydronaphthalene ester, their preparation and their therapeutic uses |
| 09/01/1998 | US5801253 Retinoic acid X-receptor ligands |
| 09/01/1998 | US5801161 Vitamin b12 deficiency |
| 08/27/1998 | WO1998037224A1 Transgenically produced non-secreted proteins |
| 08/27/1998 | WO1998037094A2 Secreted proteins and polynucleotides encoding them |
| 08/27/1998 | WO1998036770A1 Preparations for the treatment of metabolic syndrome containing human growth hormone in combination with a cortisol synthesis inhibitor |
| 08/27/1998 | WO1998036769A1 Pulsatile delivery of leptin receptor ligands |
| 08/27/1998 | WO1998036767A1 Modulation of the hypothalamic-pituitary-adrenal-adipose axis with leptin receptor ligands |
| 08/27/1998 | WO1998036764A2 Method of treating psychological and metabolic disorders using igf or igf/igfbp-3 |
| 08/27/1998 | WO1998036755A1 Sulfonylurea-glitazone synergistic combinations for diabetes |
| 08/27/1998 | WO1998024782A3 Substituted pyrimidine compounds and their use |
| 08/27/1998 | WO1998006437A3 Compositions and methods for polynucleotide delivery |
| 08/27/1998 | CA2282467A1 Preparations for the treatment of metabolic syndrome containing human growth hormone in combination with a cortisol synthesis inhibitor |
| 08/27/1998 | CA2282341A1 Modulation of the hypothalamic-pituitary-adrenal-adipose axis with leptin receptor ligands |
| 08/27/1998 | CA2282325A1 Pulsatile delivery of leptin receptor ligands |
| 08/27/1998 | CA2281949A1 Transgenically produced non-secreted proteins |
| 08/27/1998 | CA2281890A1 Method of treating psychological and metabolic disorders using igf or igf/igfbp-3 |
| 08/27/1998 | CA2281059A1 Secreted proteins and polynucleotides encoding them |
| 08/27/1998 | CA2272478A1 Sulfonylurea-glitazone synergistic combinations for diabetes |
| 08/26/1998 | EP0859834A2 A paf-acetylhydrolase and use in therapy |